Fluoroquinolones in chronic obstructive pulmonary disease.
作者信息
Colville A, Knowles M, Large D, George J, Mustchin P
出版信息
BMJ. 1994 May 28;308(6941):1437. doi: 10.1136/bmj.308.6941.1437a.
Abstract
摘要
相似文献
1
Fluoroquinolones in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的氟喹诺酮类药物。
BMJ. 1994 May 28;308(6941):1437. doi: 10.1136/bmj.308.6941.1437a.
2
Quinolones and pneumococci.喹诺酮类药物与肺炎球菌。
J Antimicrob Chemother. 2000 May;45(5):709-10. doi: 10.1093/jac/45.5.709.
3
Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae.氟喹诺酮类药物用于治疗肺炎链球菌引起的下呼吸道感染患者。
J Antimicrob Chemother. 1998 Sep;42(3):398-9. doi: 10.1093/jac/42.3.398.
4
Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.司帕沙星，一种用于治疗肺炎链球菌呼吸道感染的新一代氟喹诺酮类药物。
Drugs. 1995;49 Suppl 2:420-2. doi: 10.2165/00003495-199500492-00121.
5
Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.格帕沙星对肺炎链球菌呼吸道分离株的活性。
Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):622-3. doi: 10.1007/BF02447932.
6
Ciprofloxacin vs. the pneumococcus.环丙沙星与肺炎球菌
Chest. 2000 Oct;118(4):1226-7. doi: 10.1378/chest.118.4.1226.
7
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
N Engl J Med. 2002 Jul 4;347(1):65-7; author reply 65-7.
8
Fluoroquinolone resistance in Streptococcus pneumoniae.肺炎链球菌对氟喹诺酮类药物的耐药性。
Ann Intern Med. 1999 Aug 17;131(4):312-3. doi: 10.7326/0003-4819-131-4-199908170-00023.
9
Fluoroquinolone-resistant Streptococcus pneumoniae.耐氟喹诺酮类肺炎链球菌
Emerg Infect Dis. 2006 Sep;12(9):1462-3. doi: 10.3201/eid1209.051400.
10
Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.耐抗菌药物肺炎链球菌感染治疗中的微生物学和药效学考量
Clin Infect Dis. 2000 Aug;31 Suppl 2:S29-34. doi: 10.1086/314057.
引用本文的文献
1
Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.下呼吸道感染患者氟喹诺酮类药物的选择指南。
Drugs. 2005;65(7):949-91. doi: 10.2165/00003495-200565070-00004.
本文引用的文献
1
Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.社区获得性上呼吸道感染口服氟喹诺酮类药物治疗的风险
BMJ. 1994 Jan 15;308(6922):191-2. doi: 10.1136/bmj.308.6922.191.
2
Antibiotics in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的抗生素
BMJ. 1994 Apr 2;308(6933):871-2. doi: 10.1136/bmj.308.6933.871.
3
Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
J Antimicrob Chemother. 1994 Jan;33(1):111-8. doi: 10.1093/jac/33.1.111.
4
Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.社区获得性成人下呼吸道感染病因及转归的前瞻性研究。
Lancet. 1993 Feb 27;341(8844):511-4. doi: 10.1016/0140-6736(93)90275-l.
5
Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin.慢性阻塞性气道疾病急性加重期的治疗——阿莫西林与环丙沙星的比较
J Antimicrob Chemother. 1990 Dec;26 Suppl F:19-24. doi: 10.1093/jac/26.suppl_f.19.
Zotero 插件